RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM)

CUSIP: 76243J105

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+1,346,412
Put/Call ratio
9.6%
SEC-reported price per share
$43.33
Number of holders
166
Value change
+$55,358,404
Number of buys
86
Open additional details 1 more signal available
Number of sells
77
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
69,012,275

Security key

76243J105

Report period

Q1 2024

Institutions

166

Top holders

10

Ownership snapshot

Top reported holders of RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PRIMECAP MANAGEMENT CO/CA/
Disclosed value leader
PRIMECAP MANAGEMENT CO/CA/
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

PRIMECAP MANAGEMENT CO/CA/ leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRIMECAP MANAGEMENT CO/CA/'s linked filing trail.
Comparable ownership Top 5
PRIMECAP MANAGEMENT CO/CA/ 12%
BAKER BROS. ADVISORS LP 9.3%
BlackRock Finance, Inc. 9.2%
RA CAPITAL MANAGEMENT, L.P. 7.7%
GOLDMAN SACHS GROUP INC 7.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
12%
$370,180,229
8,052,648 shares
31 Dec 2023
BAKER BROS. ADVISORS LP
13F
Company
13F
9.3%
$294,132,839
6,398,365 shares
31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
9.2%
$291,989,948
6,351,750 shares
31 Dec 2023
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
7.7%
$245,039,040
5,330,412 shares
31 Dec 2023
GOLDMAN SACHS GROUP INC
13F
Company
13F
7.3%
$232,053,526
5,047,934 shares
31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
4.7%
$148,342,339
3,226,938 shares
31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
166
Shares
68,030,458
Rows available
166
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
166
Q1 2024 holders
166
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .